2006
DOI: 10.1016/j.biomaterials.2005.08.023
|View full text |Cite
|
Sign up to set email alerts
|

Galactose-PEG dual conjugation of β-(1→3)-d-glucan schizophyllan for antisense oligonucleotides delivery to enhance the cellular uptake☆

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
16
0

Year Published

2007
2007
2015
2015

Publication Types

Select...
5
3
2

Relationship

1
9

Authors

Journals

citations
Cited by 27 publications
(16 citation statements)
references
References 31 publications
0
16
0
Order By: Relevance
“…3)-D-glucan SPG for delivery of antisense oligonucleotides. This dual conjugation facilitates enhancement in cellular uptake along with endocytosis escape (Karinaga et al 2006). Blood clearance of SPG was found to be confirmation dependent.…”
Section: Schizophyllanmentioning
confidence: 99%
“…3)-D-glucan SPG for delivery of antisense oligonucleotides. This dual conjugation facilitates enhancement in cellular uptake along with endocytosis escape (Karinaga et al 2006). Blood clearance of SPG was found to be confirmation dependent.…”
Section: Schizophyllanmentioning
confidence: 99%
“…Reductive amination is then carried out by first treating the oxidized schizophyllan with a bisamino(polyethyleneglycol) that has been derivatized with lactose, and then with sodium cyanoborohydride. This sequence of reactions introduces lactose into schizophyllan (as in 7), which on one hand can associate with DNA, and on the other hand can be recognized by asiaoglycoprotein receptors [82][83][84][85][86][87][88][89].…”
Section: Complexation Through Nucleic Acid-polysaccharide Interactionmentioning
confidence: 99%
“…Schizophyllan has been modified with galactose and PEG units to enhance cellular uptake. It has been observed that the antisense effect was maximized with the use of schizophyllan derivative when the complex is administered to hepatoblastoma HepG2 and melanoma A375 cell lines [55]. Thus, 1,3--glucan based drug delivery devices serve as biocompatible carriers for a variety of nucleotides.…”
Section: Glucan Complexes With Polynucleotidesmentioning
confidence: 99%